BETA
Start SIP
Invest Now
Start SIP in BETA
Performance
- Low
- ₹1,354
- High
- ₹1,430
- 52 Week Low
- ₹1,354
- 52 Week High
- ₹2,000
- Open Price₹1,423
- Previous Close₹1,412
- Volume9,209
- 50 DMA₹1,556.50
- 100 DMA₹1,628.30
- 200 DMA₹1,678.40
Investment Returns
- Over 1 Month -13.76%
- Over 3 Month -18.16%
- Over 6 Month -20.92%
- Over 1 Year -23.52%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,381
- P/B Ratio
- 6.2
- Average True Range
- 77.99
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- -41.72
- RSI
- 37.59
- MFI
- 39.16
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,367.90
-44.5
(-3.15%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,483.05
- 50 Day
- ₹1,556.50
- 100 Day
- ₹1,628.30
- 200 Day
- ₹1,678.40
Resistance and Support
1411.23
- R3 1,499.57
- R2 1,469.73
- R1 1,441.07
- S1 1,382.57
- S2 1,352.73
- S3 1,324.07
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-09 | Others | To consider 1. Approve the Employee Stock Option Plan (ESOP). 2. Acquisition of equity shares of a target company from certain shareholders of the target company. 3. Other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,367 As on 10 February, 2026 | 15:35
The Market Cap of Beta Drugs is ₹1380.8 Cr As on 10 February, 2026 | 15:35
The P/E ratio of Beta Drugs is As on 10 February, 2026 | 15:35
The PB ratio of Beta Drugs is 6.2 As on 10 February, 2026 | 15:35
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.